Literature DB >> 8113396

High efficiency of muscle regeneration after human myoblast clone transplantation in SCID mice.

J Huard1, S Verreault, R Roy, M Tremblay, J P Tremblay.   

Abstract

SCID mouse tibialis anterior muscles were first irradiated to prevent regeneration by host myoblasts and injected with notexin to damage the muscle fibers and trigger regeneration. The muscles were then injected with roughly 5 million human myoblasts. 1 mo later, 16-33% of the normal number of muscle fibers were present in the injected muscle, because of incomplete regeneration. However, > 90% of these muscle fibers contained human dystrophin. Some newly formed muscle fibers had an accumulation of human dystrophin and desmin on a part of their membrane. Such accumulations have been demonstrated at neuromuscular junctions before suggesting that the new muscle fibers are innervated and functional. The same pool of clones of human myoblasts produced only < or = 4% of muscle fibers containing human dystrophin when injected in nude mice muscles. Several of the human myoblasts did not fuse and remained in interstitial space or tightly associated with muscle fibers suggesting that some of them have formed satellite cells. Moreover, cultures of 98% pure human myoblasts were obtained from transplanted SCID muscles. In some mice where the muscle regeneration was not complete, the muscle fibers containing human dystrophin also expressed uniformly HLA class 1, confirming that the fibers are of human origin. The presence of hybrid muscle fibers containing human dystrophin and mouse MHC was also demonstrated following transplantation. These results establish that in absence of an immune reaction, transplanted human myoblasts participate to the muscle regeneration with a high degree of efficacy even if the animals were killed only 1 mo after the transplantation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8113396      PMCID: PMC293882          DOI: 10.1172/JCI117011

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  38 in total

1.  Human myoblast transplantation between immunohistocompatible donors and recipients produces immune reactions.

Authors:  J Huard; R Roy; J P Bouchard; F Malouin; C L Richards; J P Tremblay
Journal:  Transplant Proc       Date:  1992-12       Impact factor: 1.066

2.  A light and electron microscopic study of dystrophin localization at the mouse neuromuscular junction.

Authors:  J Huard; L P Fortier; G Dansereau; C Labrecque; J P Tremblay
Journal:  Synapse       Date:  1992-02       Impact factor: 2.562

3.  Immunoelectron microscopic localization of dystrophin in myofibres.

Authors:  S C Watkins; E P Hoffman; H S Slayter; L M Kunkel
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

4.  Normal dystrophin transcripts detected in Duchenne muscular dystrophy patients after myoblast transplantation.

Authors:  E Gussoni; G K Pavlath; A M Lanctot; K R Sharma; R G Miller; L Steinman; H M Blau
Journal:  Nature       Date:  1992-04-02       Impact factor: 49.962

5.  Formation of new muscle fibres and tumours after injection of cultured myogenic cells.

Authors:  A Wernig; A Irintchev; A Härtling; G Stephan; K Zimmermann; A Starzinski-Powitz
Journal:  J Neurocytol       Date:  1991-12

6.  Feasibility, safety, and efficacy of myoblast transfer therapy on Duchenne muscular dystrophy boys.

Authors:  P K Law; T G Goodwin; Q Fang; V Duggirala; C Larkin; J A Florendo; D S Kirby; M B Deering; H J Li; M Chen
Journal:  Cell Transplant       Date:  1992       Impact factor: 4.064

7.  Results of a triple blind clinical study of myoblast transplantations without immunosuppressive treatment in young boys with Duchenne muscular dystrophy.

Authors:  J P Tremblay; F Malouin; R Roy; J Huard; J P Bouchard; A Satoh; C L Richards
Journal:  Cell Transplant       Date:  1993 Mar-Apr       Impact factor: 4.064

8.  Utilization of an antibody specific for human dystrophin to follow myoblast transplantation in nude mice.

Authors:  J Huard; G Tremblay; S Verreault; C Labrecque; J P Tremblay
Journal:  Cell Transplant       Date:  1993 Mar-Apr       Impact factor: 4.064

9.  Human myoblast transplantation: a simple assay for tumorigenicity.

Authors:  J P Tremblay; B Roy; M Goulet
Journal:  Neuromuscul Disord       Date:  1991       Impact factor: 4.296

10.  Use of fluorescent latex microspheres (FLMs) to follow the fate of transplanted myoblasts.

Authors:  A Satoh; J Huard; C Labrecque; J P Tremblay
Journal:  J Histochem Cytochem       Date:  1993-10       Impact factor: 2.479

View more
  27 in total

1.  Dermal fibroblasts participate in the formation of new muscle fibres when implanted into regenerating normal mouse muscle.

Authors:  D Pye; D J Watt
Journal:  J Anat       Date:  2001-02       Impact factor: 2.610

Review 2.  Are human and mouse satellite cells really the same?

Authors:  Luisa Boldrin; Francesco Muntoni; Jennifer E Morgan
Journal:  J Histochem Cytochem       Date:  2010-07-19       Impact factor: 2.479

3.  Function of skeletal muscle tissue formed after myoblast transplantation into irradiated mouse muscles.

Authors:  A Wernig; M Zweyer; A Irintchev
Journal:  J Physiol       Date:  2000-01-15       Impact factor: 5.182

4.  A novel myogenic cell line with phenotypic properties of muscle progenitors.

Authors:  Serena Zacchigna; Even K Østli; Nikola Arsic; Lucia Pattarini; Mauro Giacca; Srdjan Djurovic
Journal:  J Mol Med (Berl)       Date:  2007-10-24       Impact factor: 4.599

5.  Aldehyde dehydrogenase activity identifies a population of human skeletal muscle cells with high myogenic capacities.

Authors:  Karine Vauchez; Jean-Pierre Marolleau; Michel Schmid; Patricia Khattar; Alain Chapel; Cyril Catelain; Séverine Lecourt; Jérôme Larghéro; Marc Fiszman; Jean-Thomas Vilquin
Journal:  Mol Ther       Date:  2009-09-08       Impact factor: 11.454

6.  In vivo fluorescence imaging of muscle cell regeneration by transplanted EGFP-labeled myoblasts.

Authors:  Xiaoyin Xu; Zhong Yang; Qiang Liu; Yaming Wang
Journal:  Mol Ther       Date:  2010-02-02       Impact factor: 11.454

7.  Obestatin Increases the Regenerative Capacity of Human Myoblasts Transplanted Intramuscularly in an Immunodeficient Mouse Model.

Authors:  Icia Santos-Zas; Elisa Negroni; Kamel Mamchaoui; Carlos S Mosteiro; Rosalia Gallego; Gillian S Butler-Browne; Yolanda Pazos; Vincent Mouly; Jesus P Camiña
Journal:  Mol Ther       Date:  2017-07-24       Impact factor: 11.454

8.  Skeletal Muscle Regenerative Potential of Human MuStem Cells following Transplantation into Injured Mice Muscle.

Authors:  Judith Lorant; Charlotte Saury; Cindy Schleder; Florence Robriquet; Blandine Lieubeau; Elisa Négroni; Isabelle Leroux; Lucie Chabrand; Sabrina Viau; Candice Babarit; Mireille Ledevin; Laurence Dubreil; Antoine Hamel; Armelle Magot; Chantal Thorin; Laëtitia Guevel; Bruno Delorme; Yann Péréon; Gillian Butler-Browne; Vincent Mouly; Karl Rouger
Journal:  Mol Ther       Date:  2017-10-20       Impact factor: 11.454

9.  SCID mice containing muscle with human mitochondrial DNA mutations. An animal model for mitochondrial DNA defects.

Authors:  K M Clark; D J Watt; R N Lightowlers; M A Johnson; J B Relvas; J W Taanman; D M Turnbull
Journal:  J Clin Invest       Date:  1998-12-15       Impact factor: 14.808

10.  Human muscular fetal cells: a potential cell source for muscular therapies.

Authors:  Nathalie Hirt-Burri; Anthony S de Buys Roessingh; Corinne Scaletta; Stefan Gerber; Dominique P Pioletti; Lee Ann Applegate; Judith Hohlfeld
Journal:  Pediatr Surg Int       Date:  2008-01       Impact factor: 1.827

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.